EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

canSAR: update to the cancer translational research and drug discovery knowledgebase

Patrizio di Micco iD, Albert A Antolin iD, Costas Mitsopoulos, Eloy Villasclaras-Fernandez, Domenico Sanfelice, Daniela Dolciami, Pradeep Ramagiri, Ioan L Mica, Joseph E Tym, Philip W Gingrich, Huabin Hu, Paul Workman iD und 1 weitere

Nucleic Acids Research · 06.01.2023 · 51 (D1) · D1212-D1219

DOI: 10.1093/nar/gkac1004 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nucleic Acids Research, online erschienen am 29.11.2022. Verfasst von Patrizio di Micco und 12 weiteren Autor:innen. Beteiligte Einrichtung: The Department of Genomic Medicine & The Institute of Data Science in Oncology, MD Anderson Cancer Center, Houston, TX, USA. Hauptthemen laut MEDLINE: Drug Discovery, Knowledge Bases, Translational Research, Biomedical, Antineoplastic Agents. Die Arbeit wurde bisher 42-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Cancer Research UK, Wellcome Trust, ‘canSAR: enhancing the drug discovery knowledgebase’.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

canSAR (https://cansar.ai) is the largest public cancer drug discovery and translational research knowledgebase. Now hosted in its new home at MD Anderson Cancer Center, canSAR integrates billions of experimental measurements from across molecular profiling, pharmacology, chemistry, structural and systems biology. Moreover, canSAR applies a unique suite of machine learning algorithms designed to inform drug discovery. Here, we describe the latest updates to the knowledgebase, including a focus on significant novel data. These include canSAR’s ligandability assessment of AlphaFold; mapping of fragment-based screening data; and new chemical bioactivity data for novel targets. We also describe enhancements to the data and interface.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug DiscoveryKnowledge BasesTranslational Research, BiomedicalAntineoplastic AgentsHumansAlgorithmsNeoplasms

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • The Department of Genomic Medicine & The Institute of Data Science in Oncology, MD Anderson Cancer Center, Houston, TX, USA.
  • The Department of Data Science, The Institute of Cancer Research, London, UK.
  • Centre for Cancer Drug Discovery, The Division of Cancer Therapeutics, The Institute of Cancer Research, London, UK.

ORCID-Profile: Patrizio di Micco, Albert A Antolin, Paul Workman, Bissan Al-Lazikani

Förderung

  • Cancer Research UK
  • Wellcome Trust
  • ‘canSAR: enhancing the drug discovery knowledgebase’
  • CPRIT
  • CRUK
  • Chordoma Foundation
  • Mark Foundation
  • Wellcome Trust Sir Henry Wellcome Postdoctoral Fellowship

Zitieren

APA

di Micco, P., Antolin, A. A., Mitsopoulos, C., Villasclaras-Fernandez, E., Sanfelice, D., Dolciami, D., Ramagiri, P., Mica, I. L., Tym, J. E., Gingrich, P. W., Hu, H., Workman, P., & Al-Lazikani, B. (2023). canSAR: update to the cancer translational research and drug discovery knowledgebase. Nucleic Acids Research, 51(D1), D1212-D1219. https://doi.org/10.1093/nar/gkac1004

Vancouver

di Micco P, Antolin AA, Mitsopoulos C, Villasclaras-Fernandez E, Sanfelice D, Dolciami D, et al. canSAR: update to the cancer translational research and drug discovery knowledgebase. Nucleic Acids Research. 2023;51(D1):D1212-D1219. doi:10.1093/nar/gkac1004

BibTeX
@article{diMicco2023,
  author = {di Micco, Patrizio and Antolin, Albert A and Mitsopoulos, Costas and Villasclaras-Fernandez, Eloy and Sanfelice, Domenico and Dolciami, Daniela and Ramagiri, Pradeep and Mica, Ioan L and Tym, Joseph E and Gingrich, Philip W and Hu, Huabin and Workman, Paul and Al-Lazikani, Bissan},
  title = {canSAR: update to the cancer translational research and drug discovery knowledgebase},
  journal = {Nucleic Acids Research},
  year = {2023},
  volume = {51},
  number = {D1},
  pages = {D1212--D1219},
  doi = {10.1093/nar/gkac1004}
}
Kostenlos starten →